Back to search
FDAFDA · Food and drugs·Recall number Z-3173-2026

GM Helix Implant, REF: 109.984;

Published September 23, 2026 · Recall initiated: August 12, 2026

Summary

FDA records medical device Class II recall Z-3173-2026, published September 23, 2026 and initiated August 12, 2026. Recalling firm: Straumann USA LLC; Status: Ongoing; Reported quantity: 216; Lot: REF: 109.984; UDI: (01)7899878024552(11)251122(17)301121(10)VZPF4; Lot: VZPF4. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a discrepancy between the product identification on the packaging and the dimensions of the implant contained inside.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Straumann USA LLC
Distributor
US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, IL, KS, LA, MA, MI, MO, NC, NJ, NV, NY, OH, OK, OR, PA, SC, TX, VA, WI;
Lot
REF: 109.984; UDI: (01)7899878024552(11)251122(17)301121(10)VZPF4; Lot: VZPF4;
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was GM Helix Implant, REF: 109.984; recalled?

Yes. FDA published recall Z-3173-2026 on September 23, 2026. Reported hazard: There is a discrepancy between the product identification on the packaging and the dimensions of the implant contained inside.

What should I do if I have this product?

Voluntary: Firm initiated · Letter